Cargando…
Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain
Microglia, the innate immune cells of the brain, are activated by damage or disease. In mouse models of amyotrophic lateral sclerosis (ALS), microglia shift from neurotrophic to neurotoxic states with disease progression. It remains unclear how human microglia change relative to the TAR DNA-binding...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142752/ https://www.ncbi.nlm.nih.gov/pubmed/37118836 http://dx.doi.org/10.1186/s40478-023-01561-6 |
_version_ | 1785033688391614464 |
---|---|
author | Swanson, Molly E. V. Mrkela, Miran Murray, Helen C. Cao, Maize C. Turner, Clinton Curtis, Maurice A. Faull, Richard L. M. Walker, Adam K. Scotter, Emma L. |
author_facet | Swanson, Molly E. V. Mrkela, Miran Murray, Helen C. Cao, Maize C. Turner, Clinton Curtis, Maurice A. Faull, Richard L. M. Walker, Adam K. Scotter, Emma L. |
author_sort | Swanson, Molly E. V. |
collection | PubMed |
description | Microglia, the innate immune cells of the brain, are activated by damage or disease. In mouse models of amyotrophic lateral sclerosis (ALS), microglia shift from neurotrophic to neurotoxic states with disease progression. It remains unclear how human microglia change relative to the TAR DNA-binding protein 43 (TDP-43) aggregation that occurs in 97% of ALS cases. Here we examine spatial relationships between microglial activation and TDP-43 pathology in brain tissue from people with ALS and from a TDP-43-driven ALS mouse model. Post-mortem human brain tissue from the Neurological Foundation Human Brain Bank was obtained from 10 control and 10 ALS cases in parallel with brain tissue from a bigenic NEFH-tTA/tetO-hTDP-43∆NLS (rNLS) mouse model of ALS at disease onset, early disease, and late disease stages. The spatiotemporal relationship between microglial activation and ALS pathology was determined by investigating microglial functional marker expression in brain regions with low and high TDP-43 burden at end-stage human disease: hippocampus and motor cortex, respectively. Sections were immunohistochemically labelled with a two-round multiplexed antibody panel against; microglial functional markers (L-ferritin, HLA-DR, CD74, CD68, and Iba1), a neuronal marker, an astrocyte marker, and pathological phosphorylated TDP-43 (pTDP-43). Single-cell levels of microglial functional markers were quantified using custom analysis pipelines and mapped to anatomical regions and ALS pathology. We identified a significant increase in microglial Iba1 and CD68 expression in the human ALS motor cortex, with microglial CD68 being significantly correlated with pTDP-43 pathology load. We also identified two subpopulations of microglia enriched in the ALS motor cortex that were defined by high L-ferritin expression. A similar pattern of microglial changes was observed in the rNLS mouse, with an increase first in CD68 and then in L-ferritin expression, with both occurring only after pTDP-43 inclusions were detectable. Our data strongly suggest that microglia are phagocytic at early-stage ALS but transition to a dysfunctional state at end-stage disease, and that these functional states are driven by pTDP-43 aggregation. Overall, these findings enhance our understanding of microglial phenotypes and function in ALS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01561-6. |
format | Online Article Text |
id | pubmed-10142752 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-101427522023-04-29 Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain Swanson, Molly E. V. Mrkela, Miran Murray, Helen C. Cao, Maize C. Turner, Clinton Curtis, Maurice A. Faull, Richard L. M. Walker, Adam K. Scotter, Emma L. Acta Neuropathol Commun Research Microglia, the innate immune cells of the brain, are activated by damage or disease. In mouse models of amyotrophic lateral sclerosis (ALS), microglia shift from neurotrophic to neurotoxic states with disease progression. It remains unclear how human microglia change relative to the TAR DNA-binding protein 43 (TDP-43) aggregation that occurs in 97% of ALS cases. Here we examine spatial relationships between microglial activation and TDP-43 pathology in brain tissue from people with ALS and from a TDP-43-driven ALS mouse model. Post-mortem human brain tissue from the Neurological Foundation Human Brain Bank was obtained from 10 control and 10 ALS cases in parallel with brain tissue from a bigenic NEFH-tTA/tetO-hTDP-43∆NLS (rNLS) mouse model of ALS at disease onset, early disease, and late disease stages. The spatiotemporal relationship between microglial activation and ALS pathology was determined by investigating microglial functional marker expression in brain regions with low and high TDP-43 burden at end-stage human disease: hippocampus and motor cortex, respectively. Sections were immunohistochemically labelled with a two-round multiplexed antibody panel against; microglial functional markers (L-ferritin, HLA-DR, CD74, CD68, and Iba1), a neuronal marker, an astrocyte marker, and pathological phosphorylated TDP-43 (pTDP-43). Single-cell levels of microglial functional markers were quantified using custom analysis pipelines and mapped to anatomical regions and ALS pathology. We identified a significant increase in microglial Iba1 and CD68 expression in the human ALS motor cortex, with microglial CD68 being significantly correlated with pTDP-43 pathology load. We also identified two subpopulations of microglia enriched in the ALS motor cortex that were defined by high L-ferritin expression. A similar pattern of microglial changes was observed in the rNLS mouse, with an increase first in CD68 and then in L-ferritin expression, with both occurring only after pTDP-43 inclusions were detectable. Our data strongly suggest that microglia are phagocytic at early-stage ALS but transition to a dysfunctional state at end-stage disease, and that these functional states are driven by pTDP-43 aggregation. Overall, these findings enhance our understanding of microglial phenotypes and function in ALS. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s40478-023-01561-6. BioMed Central 2023-04-28 /pmc/articles/PMC10142752/ /pubmed/37118836 http://dx.doi.org/10.1186/s40478-023-01561-6 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Swanson, Molly E. V. Mrkela, Miran Murray, Helen C. Cao, Maize C. Turner, Clinton Curtis, Maurice A. Faull, Richard L. M. Walker, Adam K. Scotter, Emma L. Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain |
title | Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain |
title_full | Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain |
title_fullStr | Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain |
title_full_unstemmed | Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain |
title_short | Microglial CD68 and L-ferritin upregulation in response to phosphorylated-TDP-43 pathology in the amyotrophic lateral sclerosis brain |
title_sort | microglial cd68 and l-ferritin upregulation in response to phosphorylated-tdp-43 pathology in the amyotrophic lateral sclerosis brain |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10142752/ https://www.ncbi.nlm.nih.gov/pubmed/37118836 http://dx.doi.org/10.1186/s40478-023-01561-6 |
work_keys_str_mv | AT swansonmollyev microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT mrkelamiran microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT murrayhelenc microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT caomaizec microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT turnerclinton microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT curtismauricea microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT faullrichardlm microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT walkeradamk microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain AT scotteremmal microglialcd68andlferritinupregulationinresponsetophosphorylatedtdp43pathologyintheamyotrophiclateralsclerosisbrain |